Characterization of visual cognition in pre-manifest, manifest and reduced penetrance Huntington’s disease

Cognitive and visual impairment are common in Huntington's Disease (HD) and may precede motor diagnosis. We investigate the early presence of visual cognitive deficits in 181 participants, including HD carriers (40 pre-manifest, 30 early manifest, 27 manifest, and 6 reduced penetrance) and 78 healthy controls (HC). Significant differences in visual memory were observed between reduced penetrance and pre-manifest groups (p = .003), with pre-manifest showing worse performance. Age, education, CAG repeats, motor status, executive function, and verbal fluency, accounted for up to 72.8% of the variance in general and visual cognitive functions, with motor status having the strongest impact on visual domains in HD carriers. In pre-manifest HD, visual cognitive domains were primarily influenced by executive function, verbal fluency, age, and CAG repeats, while in early and manifest stages motor status and verbal fluency becomes more influential. ROC analyses showed that especially visuospatial abilities, visual memory, and visual attention (AUC = 0.927, 0.878, 0.874, respectively) effectively differentiated HC and pre-manifest from early and manifest HD. Early assessment of visual cognitive domains, particularly visual memory, could be an early marker of cognitive decline in HD. Our findings highlight the different profiles of impairment in visual cognition across HD carriers.

Authors

Institutions

Publication Details

Journal
Scientific Reports
Published
2025-02-08
DOI
https://doi.org/10.1038/s41598-025-88406-5
Citations
2
Primary Topic
Genetic Neurodegenerative Diseases
Type
article
Field-Weighted Citation Impact
1.82

Funders

Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

Characterization of visual cognition in pre-manifest, manifest and reduced penetrance Huntington’s disease

Lara Pardina, Rocío Del Pino, M. Acera, Marta Ruíz-López et al.
2 citations
Scientific Reports
Genetic Neurodegenerative Diseases
1.82
article

Characterization of visual cognition in pre-manifest, manifest and reduced penetrance Huntington’s disease

Lara Pardina, Rocío Del Pino, M. Acera, Marta Ruíz-López, Naia Ayo-Mentxakatorre, Beatriz Tijero, Rosario Sánchez‐Pernaute, Javier Ruiz‐Martínez, Iñigo Gabilondo, Johanne Somme, Tamara Fernández‐Valle, Ane Murueta‐Goyena, Juan Carlos Gómez‐Esteban, Ioana Croitoru, Andrea Gabilondo, Amaia Ortiz de Echevarrría
article en
2 citations

Abstract

Cognitive and visual impairment are common in Huntington's Disease (HD) and may precede motor diagnosis. We investigate the early presence of visual cognitive deficits in 181 participants, including HD carriers (40 pre-manifest, 30 early manifest, 27 manifest, and 6 reduced penetrance) and 78 healthy controls (HC). Significant differences in visual memory were observed between reduced penetrance and pre-manifest groups (p = .003), with pre-manifest showing worse performance. Age, education, CAG repeats, motor status, executive function, and verbal fluency, accounted for up to 72.8% of the variance in general and visual cognitive functions, with motor status having the strongest impact on visual domains in HD carriers. In pre-manifest HD, visual cognitive domains were primarily influenced by executive function, verbal fluency, age, and CAG repeats, while in early and manifest stages motor status and verbal fluency becomes more influential. ROC analyses showed that especially visuospatial abilities, visual memory, and visual attention (AUC = 0.927, 0.878, 0.874, respectively) effectively differentiated HC and pre-manifest from early and manifest HD. Early assessment of visual cognitive domains, particularly visual memory, could be an early marker of cognitive decline in HD. Our findings highlight the different profiles of impairment in visual cognition across HD carriers.

Scientific ReportsVol. 15(1)
Ikerbasque (ES), University of the Basque Country (ES), BioCruces Health research Institute (ES), Biogipuzkoa Health Research Institute (ES), Hospital Universitario Araba (ES), Policlínica Gipuzkoa (ES), Osakidetza (ES), Hospital de Cruces (ES)
Eusko Jaurlaritza
Gender equality
Openalex Percentile: Top 18%
Genetic Neurodegenerative Diseases
1.82
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.